Security key
68062P106
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)
CUSIP: 68062P106
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 91,696,172
- Total 13F shares
- 90,695,275
- Share change
- +21,306,933
- Total reported value
- $2,267,572,776
- Put/Call ratio
- 54%
- Price per share
- $25.00
- Number of holders
- 198
- Value change
- +$591,383,435
- Number of buys
- 132
- Number of sells
- 50
Report period
Q4 2025
Institutions
198
Top holders
10
OLMA full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Olema Pharmaceuticals, Inc. SEC filings
Olema Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68062P106
Recent filing periods:
Top shareholders of OLMA - Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
10%
from 13D/G
|
13,407,200
|
$173,767,954 | — | 01 Aug 2024 | |
| Logos Global Management LP |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
3,208,875
|
$31,414,886 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
2.3%
|
1,543,931
|
$7,781,412 | $0 | 31 Mar 2025 | |
| Andrew Rappaport |
3/4/5
|
Director |
0.42%
|
385,965
|
$3,392,632 | — | 21 Nov 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
7.5%
|
6,843,954
|
$67,002,310 | — | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
5.8%
|
5,295,893
|
$51,846,792 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5.2%
|
4,726,394
|
$46,271,397 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.9%
|
3,585,849
|
$35,087,532 | — | 30 Sep 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
3.8%
|
3,470,172
|
$33,972,984 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
3,197,320
|
$31,301,763 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.3%
|
3,011,969
|
$29,487,177 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.4%
|
2,217,893
|
$21,713,172 | — | 30 Sep 2025 | |
| Lightspeed Management Company, L.L.C. |
13F
|
Company |
2.1%
|
1,930,894
|
$18,903,452 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.8%
|
1,636,372
|
$16,020,082 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
1,555,887
|
$15,232,135 | — | 30 Sep 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,505,862
|
$14,742,389 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,276,005
|
$12,494,439 | — | 30 Sep 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
1.4%
|
1,249,727
|
$12,234,827 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.3%
|
1,236,915
|
$12,109,398 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
1.3%
|
1,190,654
|
$11,656,502 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
1,147,068
|
$11,229,794 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
1,093,574
|
$10,706,089 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
1,064,549
|
$10,420,648 | — | 30 Sep 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
933,541
|
$9,139,366 | — | 30 Sep 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.93%
|
854,000
|
$8,360,660 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.88%
|
803,881
|
$7,869,995 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.87%
|
802,304
|
$7,854,556 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.76%
|
693,179
|
$6,786,222 | — | 30 Sep 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.68%
|
619,874
|
$6,068,566 | — | 30 Sep 2025 | |
| Pier Capital, LLC |
13F
|
Company |
0.57%
|
524,249
|
$5,132,398 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
483,032
|
$4,728,883 | — | 30 Sep 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.48%
|
437,179
|
$4,279,983 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
395,127
|
$3,868,293 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.36%
|
331,454
|
$3,244,935 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.33%
|
299,619
|
$2,933,270 | — | 30 Sep 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.27%
|
250,000
|
$2,447,500 | — | 30 Sep 2025 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.27%
|
244,076
|
$2,389,504 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.22%
|
204,207
|
$1,999,186 | — | 30 Sep 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.19%
|
174,000
|
$1,703,460 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
169,197
|
$1,656,439 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.16%
|
148,337
|
$1,452,000 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.14%
|
128,220
|
$1,255,274 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.14%
|
124,634
|
$1,220,167 | — | 30 Sep 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.13%
|
121,342
|
$1,187,938 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
112,277
|
$1,099,192 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
109,526
|
$1,072,260 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
104,624
|
$1,024,269 | — | 30 Sep 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.11%
|
96,675
|
$946,448 | — | 30 Sep 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
94,883
|
$928,905 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
90,100
|
$882,079 | — | 30 Sep 2025 |
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) as of Q4 2025
As of 31 Dec 2025,
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) was held by
198 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,695,275 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Paradigm Biocapital Advisors LP, JANUS HENDERSON GROUP PLC, BlackRock, Inc., BVF INC/IL, FMR LLC, VANGUARD GROUP INC, Siren, L.L.C., Logos Global Management LP, and Cormorant Asset Management, LP.
This page lists
198
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
124
Q4 2025 holders
198
Holder diff
74
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.